Knight Therapeutics(KHTRF)

Description: Knight Therapeutics Inc. operates as a specialty pharmaceutical company in Canada and internationally. The company is involved in developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices. Its commercialized products include Movantik to treat opioid induced constipation; Impavido, an alkyllysophospholipid analogue drug for visceral and cutaneous Leishmaniasis; Neuragen to treat pain associated with diabetic and peripheral neuropathy; Synergy family consumer health products; and Flat Tummy Tea, a herbal detox tea. The company also develops Probuphine to treat opioid addiction; NeurAxon family for acute migraine, pain, and neurological disorders; Antibe family to treat chronic pain and inflammation; AzaSite for bacterial conjunctivitis; Iluvien to treat diabetic macular edema; Netildex for ocular inflammation; 60P family to treat tropical diseases; Advaxis family to treat HPV-associated cancers and others; PHOTOFRIN for oesophageal and endobronchial cancer, high-grade dysplasia in Barrett's oesophagus, and papillary bladder cancer; ATryn to prevent thromboembolic events; Ember family to treat osteoarthritis, chronic kidney diseases, alport syndrome, and metabolic diseases; and blood factor products. In addition, it develops FLEXISEQ for pain and joint stiffness associated with osteoarthritis; dermo-cosmetic line of products, such as Crescita family, Laboratoire Dr. Renaud, Premiology, and Pro-Derm; SEQuaderma, an active dermatology solution; HandMD skin care products; and UrgentRx, a fast-acting, portable over-the-counter medication. Further, the company develops TULSA-PRO, a medical device for prostate ablation; and 3D family diagnostic and prognostic products for cancers and neurological disorders. Additionally, it finances other life science companies; and invests in life sciences venture capital funds. The company is headquartered in Montreal, Canada.

---

Keywords: Medicine Pharmaceutical Pharmaceutical Products Pain Inflammation Skin Care Products Arthritis Pain Management Neurological Disorders Kidney Disease Dermatology Osteoarthritis Chronic Pain Metabolic Disease Chronic Kidney Disease Lipid Migraine Kidney Bladder Cancer Urological Disorders Peripheral Neuropathy Analog Constipation Addiction Diabetic Macular Edema Skeletal Disorders Venture Capital Funds Ablation Macular Edema Aging Associated Diseases Consumer Health Products HPV Axis Chronic Kidney Synergy Conjunctivitis Neurological Disorder Venture Capital Fund Tropical Diseases Alport Syndrome Opioid Induced Constipation Esophagus Probuphine Renaud Alport Bacterial Conjunctivitis Diagnostic And Prognostic Products Ocular Inflammation Papillary Bladder Cancer

---

Home Page: www.gud-knight.com

3400 De Maisonneuve Boulevard West
Montreal, QC H3Z 3B8
Canada
Phone: 514 484 4483

---

Officers

Exchange: PINK

Country: US

Currency: US Dollar ($)